Dry Salt Inhaler Claims For Allergies, Bronchitis Are Full Of Hot Air, Says UK Ad Regulator
Executive Summary
UK Advertising Standards Authority says Bioenergise made ad claims that Vytaliving dry salt inhaler could treat allergies, bronchitis and smokers cough based on a flawed study showing little improvement in subjects using the product.
You may also be interested in...
Consumer Health Care Roundup: DXM Abuse Rate Stays Steady; OTC Device Claim Fails
DXM abuse rate is up for 8th graders but down for older teens in a US federally sponsored survey; UK agency finds BioEnergiser doesn't support ad claims for OTC Sciaticure Acupressure Wrap.
IFF Narrows Focus To Fragrance, Health, Food
International Flavors & Fragrances agrees to sell its Pharma Solutions business to plant-based ingredients company Roquette for an enterprise value of $2.85bn to reduce debt and streamline its business to three segments, including scents.
MoCRA Implementation In US Election Year: Q&A With Attorney Wade Ackerman
Wade Ackerman, partner at Covington & Burling who served previously as senior FDA counsel to US Senate Health Education, Labor & Pensions (HELP) Committee leadership, discusses expectations for FDA activity under modernized cosmetics regulations in 2024.